MétaCan
Menu
Back to cohort

Putative Sarcomeric Targets of Doxorubicin Induced Matrix Metalloproteinase‐2 Activity in Cardiomyocyctes

2016· article· en· W2941580819 on OpenAlexaffabout
Andrej Roczkowsky, Brandon Chan, Bryan Hughes, Richard Schulz

Bibliographic record

VenueThe FASEB Journal · 2016
Typearticle
Languageen
FieldMedicine
TopicChemotherapy-induced cardiotoxicity and mitigation
Canadian institutionsUniversity of Alberta
Fundersnot available
KeywordsDoxorubicinHT1080FibrosarcomaMatrix metalloproteinaseIntracellularChemistryCardiotoxicityLactate dehydrogenasePharmacologyOxidative stressCancer researchBiochemistryMedicineInternal medicineEnzymePathologyChemotherapyToxicity

Abstract

fetched live from OpenAlex

Anthracyclines, such as doxorubicin, are used to treat a variety of cancers. However, doxorubicin's therapeutic utility is limited because it causes dose‐dependent myocardial injury, which may lead to heart failure in up to 11% of patients. Doxorubicin triggers this injury, in part, by stimulating cellular oxidative stress. Oxidative stress is known to activate matrix metalloproteinase‐2 (MMP‐2), an extra‐ and intra‐cellular protease, which has been implicated in many heart pathologies. Activated intracellular MMP‐2 has been shown to proteolyze sarcomeric proteins α‐actinin, troponin I, and the regulatory protein glycogen synthase kinase‐3β (GSK‐3β) in cardiac tissue or cells under oxidative stress, impairing contractile function. We hypothesized that intracellular MMP‐2 plays a role in doxorubicin cardiotoxicity by proteolyzing these substrates. Neonatal rat ventricular myocytes (NRVM) and human fibrosarcoma (HT1080) cells were treated with doxorubicin (0.5 μM) ± selective MMP‐2 inhibitors ARP‐100 (1 μM) or ONO‐4817 (1 μM) for 2–48 hr. Cell death was evaluated by lactate dehydrogenase release, MMP‐2 activity was measured by gelatin zymography, and MMP‐2 protein and its protein target levels were analyzed by immunoblot. Doxorubicin was used at a concentration which caused 15% cell death in neoplastic HT1080 cells but none in NRVM after 24 hr. In NRVMs, 24 hr doxorubicin increased intracellular MMP‐2 activity up to 311% relative to vehicle control, and this was attenuated by 60% with ARP‐100 or ONO‐4817. 24 hr doxorubicin‐induced MMP‐2 activation is caused, in part, by a 213% increase in MMP‐2 protein levels. Doxorubicin reduced troponin I levels by 40%, however, this was not normalized by ARP‐100 or ONO‐4817. There were no significant changes in α‐actinin or GSK‐3β levels. Doxorubicin at an antitumour concentration activates myocardial MMP‐2 in part by increasing MMP‐2 protein levels. The role of doxorubicin‐induced MMP‐2 activation on the reduction of cellular troponin I levels needs further investigation. Other potential MMP‐2 targets in the sarcomere (eg. titin, myosin light chain‐1) and in other cellular compartments need to be analyzed to better understand the pathophysiological actions of doxorubicin in cardiac myocytes. Support or Funding Information Canadian Institutes of Health Research Foundation Scheme Grant (to RS); Women and Children's Health Research Institute Summer Studentship (to AR).

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Bench or experimental · Consensus signal: Bench or experimental
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.001
Threshold uncertainty score0.004

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.021
GPT teacher head0.288
Teacher spread0.267 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designBench or experimental
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2016
Admission routes2
Has abstractyes

Explore more

Same venueThe FASEB JournalSame topicChemotherapy-induced cardiotoxicity and mitigationFrench-language works237,207